Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

GLP-1 and Intestinal Diseases

Open access

Abstract

Accumulating evidence implicates glucagon-like peptide-1 (GLP-1) to have, beyond glucose maintenance, a beneficial role in the gastrointestinal tract. Here, we review emerging data investigating GLP-1 as a novel treatment for intestinal diseases, including inflammatory bowel diseases, short-bowel syndrome, intestinal toxicities and coeliac disease. Possible beneficial mechanisms for these diseases include GLP-1′s influence on gastric emptying, its anti-inflammatory properties and its intestinotrophic effect. The current knowledge basis derives from the available GLP-1 agonist treatments in experimental animals and small clinical trials. However, new novel strategies including dual GLP-1/GLP-2 agonists are also in development for the treatment of intestinal diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines9040383

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 95 references

Research works printed but not linked: 1

  1. Chassaing, 2008, Dextran Sulfate Sodium-Induced Colitis Model, Curr. Protoc. Immunol., 23, 1

Cited by

See all 65

Metadata

Authors
Hunt, J. E., Holst, J. J., Jeppesen, P. B., & Kissow, H.
Affiliations
  • University of Copenhagen (DK)
  • Rigshospitalet (DK)
Corresponding author
Kissow, Hannelouise
Venue
Biomedicines
Publisher
MDPI AG
Published
2021-04-05
Volume
9
Issue
4
Pages
383
ISSN
2227-9059 (ISSN-L)
OpenAlex
W3143157476
Cited by
65
References
95
Citations by year
2026: 10 · 2025: 15 · 2024: 14 · 2023: 15 · 2022: 10 · 2021: 1
FWCI
1.54
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Lundbeckfonden (R263-2017-3740)
  • Novo Nordisk Foundation Center for Basic Metabolic Research (NNF18CC0034900)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
glucagon-like peptide-1, GLP-1 receptor agonists, intestinal diseases, inflammatory bowel disease, short bowel syndrome, intestinal toxicity, celiac disease, gastric emptying, anti-inflammatory activity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GLP-1 and Intestinal Diseases. https://app.cochat.ai/papers/10.3390/biomedicines9040383
The paper
Hunt, J. E., Holst, J. J., Jeppesen, P. B., & Kissow, H. (2021). GLP-1 and Intestinal Diseases. Biomedicines. https://doi.org/10.3390/biomedicines9040383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.